Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

psoralidin MeSH Supplementary Concept Data 2025


MeSH Supplementary
psoralidin
Unique ID
C102768
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C102768
Entry Term(s)
3,9-dihydroxy-2-prenylcoumestan
3-benzofurancarboxylic acid, 2-(2,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl)-6-hydroxy-, delta-lactone
6H-benzofuro(3,2-C)(1)benzopyran-6-one, 3,9-bis(acetyloxy)-2-(3-methyl-2-buten-1-yl)-
6H-benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-buten-1-yl)-
psoralidin diacetate
Pharm Action
Estrogen Receptor Modulators
Registry Numbers
G16ZUQ069L
6SJB56Z88I
Related Numbers
18642-23-4
6SJB56Z88I
Heading Mapped to
*Benzofurans
*Coumarins
Frequency
49
Source
Planta Med 1996 Aug;62(4):353-4
Date of Entry
1997/01/13
Revision Date
2022/08/23
psoralidin Preferred
psoralidin diacetate Narrower
page delivered in 0.005s